Hammerson Plc (LON:HMSO)
London · Delayed Price · Currency is GBP · Price in GBp 300.80
+0.80 (0.27%)
Aug 8, 2025, 4:35 PM BST
Checkpoint Therapeutics Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Rental Revenue | 98.9 | 81.8 | 92.8 | 90.2 | 90.3 | 98.1 | Upgrade |
Property Management Fees | 10.4 | 10.7 | 14.9 | 17 | 20.3 | 23.7 | Upgrade |
Other Revenue | 128.3 | 108.2 | 111.1 | 180.8 | 166.5 | 98.1 | Upgrade |
| 237.6 | 200.7 | 218.8 | 288 | 277.1 | 219.9 | Upgrade | |
Revenue Growth (YoY | 14.56% | -8.27% | -24.03% | 3.93% | 26.01% | -48.67% | Upgrade |
Property Expenses | 58.6 | 49.5 | 43.8 | 37.1 | 49.7 | 63.5 | Upgrade |
Selling, General & Administrative | 43.8 | 43.5 | 51.1 | 59.5 | 70.9 | 67.5 | Upgrade |
Other Operating Expenses | -3.7 | 0.5 | - | - | 0.7 | 2.8 | Upgrade |
Total Operating Expenses | 98.7 | 93.5 | 94.9 | 96.6 | 121.3 | 133.8 | Upgrade |
Operating Income | 138.9 | 107.2 | 123.9 | 191.4 | 155.8 | 86.1 | Upgrade |
Interest Expense | -64.2 | -68.7 | -72 | -73.4 | -77.4 | -95.5 | Upgrade |
Interest & Investment Income | 43.2 | 41.1 | 30.9 | 26.1 | 15.1 | 9.6 | Upgrade |
Currency Exchange Gain (Loss) | 9.9 | 9.9 | 20.1 | - | 11 | 5.2 | Upgrade |
Other Non-Operating Income | -25.2 | -26.7 | 5 | -14.4 | -14 | 13.7 | Upgrade |
EBT Excluding Unusual Items | 102.6 | 62.8 | 107.9 | 129.7 | 90.5 | 19.1 | Upgrade |
Gain (Loss) on Sale of Investments | -56.9 | -70.4 | -116.3 | -205.3 | -307.6 | -1,207 | Upgrade |
Gain (Loss) on Sale of Assets | 1.8 | -9.2 | 1.3 | 0.7 | 8.9 | -107.3 | Upgrade |
Asset Writedown | 16.8 | -20.6 | -45.2 | -82.7 | -169.6 | -442.7 | Upgrade |
Other Unusual Items | -0.2 | - | - | -1.3 | -21.6 | 1.2 | Upgrade |
Pretax Income | 60.8 | -42.3 | -65.5 | -164 | -408 | -1,736 | Upgrade |
Income Tax Expense | 2.6 | 2.5 | 0.7 | 0.2 | 1.3 | 0.5 | Upgrade |
Earnings From Continuing Operations | 58.2 | -44.8 | -66.2 | -164.2 | -409.3 | -1,737 | Upgrade |
Earnings From Discontinued Operations | 11.1 | -481.5 | 14.8 | - | -19.8 | 1.9 | Upgrade |
Net Income to Company | 69.3 | -526.3 | -51.4 | -164.2 | -429.1 | -1,735 | Upgrade |
Minority Interest in Earnings | -0.2 | - | - | - | - | 0.1 | Upgrade |
Net Income | 69.1 | -526.3 | -51.4 | -164.2 | -429.1 | -1,735 | Upgrade |
Net Income to Common | 69.1 | -526.3 | -51.4 | -164.2 | -429.1 | -1,735 | Upgrade |
Basic Shares Outstanding | 491 | 497 | 497 | 494 | 492 | 278 | Upgrade |
Diluted Shares Outstanding | 492 | 497 | 497 | 494 | 492 | 278 | Upgrade |
Shares Change (YoY) | -1.12% | -0.08% | 0.65% | 0.43% | 76.93% | 1716.17% | Upgrade |
EPS (Basic) | 0.14 | -1.06 | -0.10 | -0.33 | -0.87 | -6.24 | Upgrade |
EPS (Diluted) | 0.14 | -1.06 | -0.10 | -0.33 | -0.87 | -6.24 | Upgrade |
Dividend Per Share | 0.160 | 0.156 | 0.150 | 0.020 | 0.040 | 0.040 | Upgrade |
Dividend Growth | 4.23% | 4.20% | 650.00% | -50.00% | - | -99.28% | Upgrade |
Operating Margin | 58.46% | 53.41% | 56.63% | 66.46% | 56.23% | 39.15% | Upgrade |
Profit Margin | 29.08% | -262.23% | -23.49% | -57.01% | -154.85% | -788.90% | Upgrade |
EBITDA | 140.1 | 108.6 | 126.9 | 192.4 | 156.9 | 87.5 | Upgrade |
EBITDA Margin | 58.97% | 54.11% | 58.00% | 66.81% | 56.62% | 39.79% | Upgrade |
D&A For Ebitda | 1.2 | 1.4 | 3 | 1 | 1.1 | 1.4 | Upgrade |
EBIT | 138.9 | 107.2 | 123.9 | 191.4 | 155.8 | 86.1 | Upgrade |
EBIT Margin | 58.46% | 53.41% | 56.63% | 66.46% | 56.23% | 39.15% | Upgrade |
Effective Tax Rate | 4.28% | - | - | - | - | - | Upgrade |
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.